14 students awarded CURE Fellowships uky.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uky.edu Daily Mail and Mail on Sunday newspapers.
– Late-breaking phase 3 data for KONFIDENT trial on Sunday, February 25, 2024 –CAMBRIDGE, Mass. & SALISBURY, England (BUSINESS WIRE) $KALV KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule pro.
Students selected for the Undergraduate Summer Training in Cardiovascular Research program receive a stipend and are paired with a faculty mentor and work full-time in their laboratories.